Drug intelligence / Profile preview

indapamide + perindopril

Development stage
Phase 4
Lead developer
Servier
Modality
Small Molecules, Drug Delivery Systems
Administration
Oral
01

Overview

Indapamide + perindopril is a fixed-dose combination medication containing two active ingredients: indapamide (a thiazide-like diuretic) and perindopril (an angiotensin-converting enzyme [ACE] inhibitor). It is primarily used for the treatment of essential hypertension (high blood pressure). Perindopril lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II—a potent vasoconstrictor—thereby reducing total peripheral resistance and aldosterone secretion. Indapamide acts mainly by inhibiting sodium and chloride reabsorption in the distal convoluted tubule of the kidney, leading to increased urine output and reduced blood volume; it also has direct effects on vascular smooth muscle. The combination provides synergistic antihypertensive effects with improved arterial compliance and reduced cardiovascular risk compared to monotherapy. Clinical studies have shown that this combination reduces both systolic and diastolic blood pressure effectively in patients with moderate to severe hypertension—including those with diabetes—and may confer additional benefits such as reduction in left ventricular hypertrophy, improved arterial distensibility, renal protection, and decreased risk of microvascular/macrovascular complications[1][2][6][8].

Brand names
PreteraxCoversyl PlusNoliprelAPO-Perindopril/Indapamide
Other names
perindopril/indapamideperindopril erbumine/indapamide
02

Targets

ACE (Angiotensin Converting Enzyme)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)LTCC (Voltage-gated calcium channel (L-type))

Beyond the preview

Go deeper on indapamide + perindopril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indapamide + perindopril.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call